[English] 日本語
Yorodumi- PDB-9bnc: Collagen XVIII trimerization domain with introduced inter-chain d... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 9bnc | ||||||
|---|---|---|---|---|---|---|---|
| Title | Collagen XVIII trimerization domain with introduced inter-chain disulfide bond, E31C-V37C | ||||||
Components | Collagen alpha-1(XVIII) chain | ||||||
Keywords | STRUCTURAL PROTEIN / Trimer / Disulfide / Biologic scaffold | ||||||
| Function / homology | Function and homology informationresponse to hydrostatic pressure / Collagen chain trimerization / extracellular matrix structural constituent conferring tensile strength / Collagen biosynthesis and modifying enzymes / endothelial cell morphogenesis / Laminin interactions / collagen trimer / Assembly of collagen fibrils and other multimeric structures / Activation of Matrix Metalloproteinases / Collagen degradation ...response to hydrostatic pressure / Collagen chain trimerization / extracellular matrix structural constituent conferring tensile strength / Collagen biosynthesis and modifying enzymes / endothelial cell morphogenesis / Laminin interactions / collagen trimer / Assembly of collagen fibrils and other multimeric structures / Activation of Matrix Metalloproteinases / Collagen degradation / basement membrane / Integrin cell surface interactions / visual perception / animal organ morphogenesis / skeletal system development / : / angiogenesis / cell adhesion / endoplasmic reticulum lumen / response to xenobiotic stimulus / negative regulation of cell population proliferation / extracellular space / extracellular exosome / extracellular region / metal ion binding Similarity search - Function | ||||||
| Biological species | Homo sapiens (human) | ||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 1.4 Å | ||||||
Authors | Young, T. | ||||||
| Funding support | United States, 1items
| ||||||
Citation | Journal: Commun Biol / Year: 2025Title: Development of an ultrahigh affinity, trimeric ACE2 biologic as a universal SARS-CoV-2 antagonist. Authors: Juliet Gonzales / Tynan Young / Hyeran Choi / Miso Park / Yead Jewel / Chengcheng Fan / Rahul Purohit / Pamela J Bjorkman / John C Williams / ![]() Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the COVID-19 pandemic, utilizes membrane-bound, angiotensin-converting enzyme II (ACE2) for internalization and infection. ...Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the COVID-19 pandemic, utilizes membrane-bound, angiotensin-converting enzyme II (ACE2) for internalization and infection. We describe the development of a biologic that takes advantage of the proximity of the N-terminus of bound ACE2 to the three-fold symmetry axis of the spike protein to create an ultrapotent, trivalent ACE2 entry antagonist. Distinct disulfide bonds were added to enhance serum stability and a single point mutation was introduced to eliminate enzymatic activity. Through surface plasmon resonance, pseudovirus neutralization assays, and single-particle cryo-electron microscopy, we show this antagonist binds to and inhibits SARS-CoV-2 variants. We further show the antagonist binds to and inhibits a 2003 SARS-CoV-1 strain. Collectively, structural insight has allowed us to design a universal trivalent antagonist against all variants of SARS-CoV-2 tested, suggesting it will be active against the emergence of future mutants. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 9bnc.cif.gz | 81.3 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb9bnc.ent.gz | 60.7 KB | Display | PDB format |
| PDBx/mmJSON format | 9bnc.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 9bnc_validation.pdf.gz | 452.2 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 9bnc_full_validation.pdf.gz | 453.2 KB | Display | |
| Data in XML | 9bnc_validation.xml.gz | 12.5 KB | Display | |
| Data in CIF | 9bnc_validation.cif.gz | 16.8 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/bn/9bnc ftp://data.pdbj.org/pub/pdb/validation_reports/bn/9bnc | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9bnbC ![]() 9bndC ![]() 9bneC ![]() 9bnfC ![]() 9bngC C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| Unit cell |
|
-
Components
| #1: Protein | Mass: 6477.461 Da / Num. of mol.: 3 / Fragment: trimerization domain / Mutation: E31C, V37C Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: COL18A1 / Production host: ![]() #2: Chemical | ChemComp-SO4 / | #3: Chemical | ChemComp-PEG / | #4: Water | ChemComp-HOH / | Has ligand of interest | N | Has protein modification | Y | |
|---|
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 1.94 Å3/Da / Density % sol: 36.72 % |
|---|---|
| Crystal grow | Temperature: 293 K / Method: vapor diffusion, sitting drop Details: 0.2 M Lithium Sulfate, 0.1 M Tris HCl, pH 8.5, 25% (w/v) PEG3350 |
-Data collection
| Diffraction | Mean temperature: 80 K / Serial crystal experiment: N |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: NSLS-II / Beamline: 17-ID-2 / Wavelength: 0.979338 Å |
| Detector | Type: DECTRIS EIGER X 16M / Detector: PIXEL / Date: Mar 4, 2023 |
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 0.979338 Å / Relative weight: 1 |
| Reflection | Resolution: 1.4→32.01 Å / Num. obs: 29542 / % possible obs: 97.39 % / Redundancy: 11.5 % / Biso Wilson estimate: 13.26 Å2 / CC1/2: 0.999 / CC star: 1 / Rmerge(I) obs: 0.05122 / Rpim(I) all: 0.01488 / Rrim(I) all: 0.05341 / Net I/σ(I): 26.71 |
| Reflection shell | Resolution: 1.4→1.45 Å / Redundancy: 5.2 % / Rmerge(I) obs: 0.215 / Num. unique obs: 2435 / CC1/2: 0.956 / CC star: 0.989 / Rpim(I) all: 0.1018 / Rrim(I) all: 0.2396 / % possible all: 81.41 |
-
Processing
| Software |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENT / Resolution: 1.4→32.01 Å / SU ML: 0.12 / Cross valid method: FREE R-VALUE / σ(F): 1.36 / Phase error: 19.07 / Stereochemistry target values: ML
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.1 Å / Solvent model: FLAT BULK SOLVENT MODEL | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 1.4→32.01 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell |
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
X-RAY DIFFRACTION
United States, 1items
Citation








PDBj














